The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

about

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

Item

http://www.wikidata.org/entity/Q35999601

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

@ast

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

@en

type

Item

label

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

@ast

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

@en

prefLabel

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

@ast

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

@en

P1476

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.

@en

P2093

Amit G Singal

http://www.w3.org/2001/XMLSchema#string

Neehar D Parikh

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Model to estimate survival in ambulatory patients with hepatocellular carcinoma.

Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.

Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma.

P304

e1002005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1002005

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27116028

http://www.w3.org/2001/XMLSchema#string

P932

4846025

http://www.w3.org/2001/XMLSchema#string